Find Federal Grants
Role of Astrocytes in Degeneration of the Neurovascular Unit in AD/ADRDs (R01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-22-037
HEAL initiative: Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression Without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development) (UG3/UH3 Clinical Trials Not Allowed)
National Institutes of Health · RFA-HL-22-013
Health Resources and Services Administration · HRSA-22-069
Ryan White HIV/AIDS Program Part C Early Intervention Services Program: Limited Existing Geographic Service Areas
Health Resources and Services Administration · HRSA-22-017
Ryan White HIV/AIDS Program Part C Early Intervention Services Program: New Geographic Service Areas
Health Resources and Services Administration · HRSA-22-016
Limited Competition: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)
National Institutes of Health · PAR-21-346
National Institutes of Health · PAR-21-351
Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional)
National Institutes of Health · PAR-21-344
The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional)
National Institutes of Health · PAR-21-348
National Institutes of Health · RFA-AI-21-065
NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed)
National Institutes of Health · PAR-22-021
Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (R24 Clinical Trials Not Allowed)
National Institutes of Health · PAR-21-326
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed)
National Institutes of Health · RFA-OD-21-007
Effectiveness and Implementation Research for Post-Acute Interventions to Optimize Long-Term Mental Health Outcomes in Low- and Middle-Income Countries (R34 Clinical Trial Optional)
National Institutes of Health · RFA-MH-22-100
Health Resources and Services Administration · HRSA-22-043
Limited Competition: Renewal of the Caenorhabditis Intervention Testing Program (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AG-22-029
Agency for International Development · 72036721RFA00005
World Trade Center Health Research related to WTC Survivors (U01-No Applications with Responders Accepted)
Centers for Disease Control and Prevention - ERA · RFA-OH-22-004
Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
National Institutes of Health · PAR-21-338
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
National Institutes of Health · PAR-21-329